At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
75 g glucose solutionother
Likely dose
75 g glucose solutionfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hyperglycemia and Mitochondrial Function in The Endothelium of Humans
In Brief
An observational study evaluating 75 g glucose solution for Diabetes and Hyperglycemia. Completed, enrolled 35 participants across 1 site.
Detailed Summary
In this study, the investigators will test the hypothesis that acute in vivo exposure to hyperglycemia increases mitochondrial network fragmentation and mitochondrial reactive oxygen species production (ROS) production in human arterial endothelial cells.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Hyperglycemia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 2016
Enrollment StartMar 2016
Primary CompletionFeb 2022
Study CompletionNov 2022
TodayJul 2026
First PostedFeb 15, 2016
Enrollment StartMar 9, 2016
Primary CompletionFeb 28, 2022
Study CompletionNov 22, 2022
TodayJul 2, 2026
Enrollment to primary: 6.0 yearsPosted 10.4 years ago
Interventions
75 g glucose solutionother
This is the same as the standard oral glucose challenge dose and route given clinically